0001104659-19-074969.txt : 20191220 0001104659-19-074969.hdr.sgml : 20191220 20191220160520 ACCESSION NUMBER: 0001104659-19-074969 CONFORMED SUBMISSION TYPE: RW PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20191220 DATE AS OF CHANGE: 20191220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PROTEON THERAPEUTICS INC CENTRAL INDEX KEY: 0001359931 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: RW SEC ACT: SEC FILE NUMBER: 333-230285 FILM NUMBER: 191301327 BUSINESS ADDRESS: STREET 1: 200 WEST STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-890-0102 MAIL ADDRESS: STREET 1: 200 WEST STREET CITY: WALTHAM STATE: MA ZIP: 02451 RW 1 a19-26707_1rw.htm RW

 

Proteon Therapeutics, Inc.

200 West Street

Waltham, MA 02451

 

December 20, 2019

 

VIA EDGAR

 

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Attention:                        Joseph McCann

 

Re:                          Proteon Therapeutics, Inc. Request to Withdraw Registration Statement on Form S-1 (File No. 333-230285)

 

Ladies and Gentlemen:

 

Pursuant to Rule 477 under the Securities Act of 1933, as amended (the “Securities Act”), Proteon Therapeutics, Inc. (the “Registrant”) hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) consent to the withdrawal of the Registration Statement on Form S-1 (File No. 333-230285), together with all exhibits and amendments thereto (collectively, the “Registration Statement”) effective as of the date hereof or as soon as practicable thereafter. The Registration Statement was initially filed with the Commission on March 14, 2019.

 

The Registration Statement has not been declared effective and no securities covered by the Registration Statement have been issued or sold.  The Registrant has decided not to pursue the offering due to market conditions. Based on the foregoing, the Registrant submits that the withdrawal of the Registration Statement is consistent with the public interest and protection of investors.

 

In accordance with Rule 457(p) under the Securities Act, the Registrant requests that all fees paid to the Commission in connection with the filing of the Registration Statement be credited to the Registrant’s account for any future use.

 

Pursuant to Rule 477(b), the Registrant understands that this request for withdrawal of the Registration Statement will be deemed granted as of the date hereof unless the Registrant receives notice from the Commission within 15 days of the date hereof that such request will not be granted.

 

If you have any questions with respect to this matter, please contact Tara R. McElhiney of Morgan, Lewis & Bockius LLP at (713) 890-5732.

 

[Remainder of page intentionally left blank]

 

 

 

Very truly yours,

 

 

 

Proteon Therapeutics, Inc.

 

 

 

 

By:

/s/ George Eldridge

 

 

George Eldridge,

 

 

Senior Vice President, Chief Financial Officer, Treasurer and Assistant Secretary

 

CC:

Timothy P. Noyes, Proteon Therapeutics, Inc.

 

Julio E. Vega, Morgan, Lewis & Bockius LLP

 

Tara R. McElhiney, Morgan, Lewis & Bockius LLP

 

Zachary E. Zemlin, Morgan, Lewis & Bockius LLP

 

 

[Proteon Therapeutics, Inc. — Signature Page to Registration Withdrawal Request]